An Exquisitely Sensitive Method for Mutation Detection in Solid and Liquid Biopsies.
This exquisitely sensitive method allows detection of low copy-number mutant alleles (down to 1 copy) in a mix of wild type alleles.
Patent applica tion submi tted
Development partner, Commercial partner, Licensing
About University of Nottingham
The University of Nottingham produces world-changing research by focussing on the problems and challenges that affect societies and people on a wide scale. More than 80% of Nottingham research is ranked in the highest categories ‘world-leading’ or ‘internationally excellent’.
Mutation detection is of specific interest in cancer screening, cancer surveillance, predictive testing, treatment- monitoring and tumour genotyping. Techniques for detecting mutations which are in low copy number (in a background of wild-type DNA) are expensive and/or limited in their application. This is a simple technology which can identify low copy-number mutant alleles in a range of sample types including poor quality templates (such as formalin-fixed paraffin embedded (FFPE) tissue) and in bodily fluids (such as blood, urine etc.). The high degree of specificity allows for multiplexing with high sensitivity. This opens the possibility of analysing a single sample for a range of low abundance mutations in one test. The speed and simplicity of the technique could allow liquid biopsy testing within the me frame of an outpatient appointment.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.